FibroBiologics, Inc. (NASDAQ:FBLG) Given Consensus Recommendation of “Buy” by Analysts
FibroBiologics, Inc. (NASDAQ:FBLG – Get Free Report) has received a consensus rating of “Buy” from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target […]
FibroBiologics, Inc. (NASDAQ:FBLG – Get Free Report) has received a consensus rating of “Buy” from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target […]
